image
Healthcare - Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - REVENUE

Revenue HALO - Halozyme Therapeutics, Inc.

image
829 M
LAST VALUE
36.77%
2 YEAR CAGR
40.43%
5 YEAR CAGR
31.22%
10 YEAR CAGR